chrisvoncsefalvay/vaers-outcomes huggingface dataset:
FEVER SORENESS JOINT PAIN SORE THROAT HEART RAATE 155 ANXIETY
sick; It was like a bad flu; This is a spontaneous report from Pfizer-sponsored program, COVID 19  from a contactable consumer. This consumer reported same events for 3 patients. This is 3rd of 3 reports.   A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Everyone that the reporter knew that has gotten the vaccine so far has all gotten sick for 24 to 48 hours. The patient was one of them. The way they described it was it was like a bad flu. The outcome of the events was unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) :  same reporter,event, suspect and diferent patient.;same reporter,event, suspect and diferent patient.
Lymph nodes in right arm pit is swollen and is the size of a golf ball, it?s also painful.
Fainting twice; Low blood pressure; Sweating like hell; Dizziness; Significant chill; Body was feeling hot; A spontaneous report was received from a consumer, a 52 years-old male patient, unknown race and ethnicity, who was administered Moderna's COVID-19 vaccine, who experienced fainting twice (syncope), low blood pressure (hypotension), sweating like hell (hyperhidrosis), dizziness, significant chills (chill), and body was feeling hot (pyrexia).   The patient's current conditions included epilepsy and slight cholesterol. Historical condition was not reported.  Products known to have been used by the patient, within two weeks prior to the event, included eslicarbazepine acetate, simvastatin, atorvastatin, sertraline hydrochloride, acetylsalicylic acid, ubidecarenone, vitamins nos, fish oil and cyanocobalamin.  On 13 Feb 2021, prior to the onset of symptoms, the patient received their second planned dose of mRNA-1273, (lot number: 030M20A), intramuscularly into right upper arm for prophylaxis of COVID-19 infection.   On 13 Feb 2021, after administering the vaccine, patient stated that everything was normal. The patient stated that he went to bed at 9 pm and at 11 pm, he started feeling significant chill and body was feeling hot. On 14 Feb 2021, at 2 am, the patient woke up to go restroom because he was sweating like hell and felt dizziness. The patient's wife noticed that the patient had fainted, and she stood him up and fainted again. His wife made him sat down on the bed and called 911. Once the paramedics arrived, the patient underwent electrocardiogram (EKG) that was normal and checked his blood pressure (BP) that was at 95/82 (unknow units). The patient stated that his BP was usually normal at 120/80 or 85. The paramedics took him to hospital. In the ambulance, they performed another EKG and BG which came out to be normal. The patient was taken to the hospital and they performed multiple blood test that came out to be normal. The patient stated that the nurse gave him unspecified intravenous (IV) liquid as treatment medication for the events which he does not remember. The patient also informed that the doctors concluded that this may happen due to Moderna COVID-19 vaccine. The patient was discharge from the hospital at 4:14 am of 14 Feb 2021. The patient does have light dizziness but not heavy and no other symptoms.  The outcome for the event(s), fainting twice, low blood pressure, sweating like hell, significant chills, and body was feeling hot were considered as resolved/recovered on 14 Feb 2021 and that of event, dizziness, was reported as not recovered.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Further information has been requested.
Approximately 24  hours after vaccination experienced lack of movement in right arm from elbow to shoulder. Arm is still sore today (Tuesday) but she is able to move arm.
given 3rd dose of varicella vaccine in error. (only requires 2 doses)   no reactions at time of vaccine or report
Chest pain; Not feeling well; This is a spontaneous report from a contactable consumer or other non hcp. The consumer (mother) reported for (daughter) that 12-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: not reported), dose 2 via an unspecified route of administration on 22Jun2021 as dose 2, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unknown route of administration on 01Jun2021 (Batch/Lot number: Not reported) as dose 1, single for covid-19 immunization. On an unknown date, the patient experienced chest pain and not feeling well. It was reported that caller was calling now on behalf of her daughter, she is 12 years old. She had her first dose Pfizer COVID 19 Vaccine 01Jun2021, second dose is 22Jun2021, that is yesterday. After having the second dose of Pfizer Covid 19 Vaccine she was experiencing chest pain and she was complaining about it. The clinical outcome of both events was unknown.  Information regarding the lot/batch number has been requested.
Muscle pain ran down arm to elbow & went back up. Still sore now but not as bad. Pt had to baby arm. As of today still sore.
Raised rash with papules that were very itchey at the injection site. Rash extended 5 inches long and 3 inches wide.
Gabe seemed fine and we were talking with his father.  He appeared to faint and hit the floor from his seated position, banging his head on the refrigerator.  He appeared to have a convulsion where he scraped his forehead.  His father sat on the floor and spoke to the patient until he regained consciousness.  He stayed for 30 minutes in the pharmacy area without further problems.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021 at 4:08 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 03-Apr-2021 at 4:08 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 19.62. Concomitant products were not provided. On 03-Apr-2021, Excursion time was 09 AM, temperature was 34, total doses given for the day was 210, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 30-Mar-2021, vial was moved to clinic on 03-Apr-2021. 20 vials were sent to clinic. Vaccine BUD date was 29-Apr-2021. On 03-Apr-2021, vials were stored in cooler 1, following are the time and temperature respectively, 8 AM: 38, 9 AM: 34, 10 AM: 38, 11 AM: 42, 12 PM: 41, 1PM: 41, 2 PM: 41, 3 PM: 40, 4 PM: 40 and 5 PM: 41. The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature. It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F. Treatment medications were not reported.
Patient developed hematoma size described as large.  Patient has had joint issues since the shot and cannot fully use her left arm as she has in the past.  It has become difficult to lift above 90 degrees.
no adverse effect; multiple patients were vaccinated with improperly stored VAQTA on multiple dates; This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 12-OCT-2018, the patient was vaccinated with improperly stored hepatitis a vaccine, inactivated(VAQTA) lot # R006209, expiry date 16-MAR-2019 for prophylaxis.  No adverse event was reported. Previous temperature excursion was reported. Data logger was involved.
Asthma has worsened; fell; she was hurt, her knee is swollen and she hit her head; she was hurt, her knee is swollen and she hit her head; Dominant Arm became weak, no pain; Little pain - clarified later as just to injection site; Little Headache; This is a spontaneous report from a contactable consumer (patient).  A 57-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Left arm on 27Feb2021 13:15 (Batch/Lot Number: EN6198), at the age of 57-years at vaccination, as SINGLE DOSE for COVID-19 immunisation.  Medical history included ongoing cerebral palsy, ongoing asthma, ongoing epilepsy, ongoing pacemaker user, depression and pain, not sleeping, high Blood Pressure, speech impediment. Historical vaccine includes shingles shot and her arm was very very sore, felt horrible not sure, horrible in general for a few days. Ongoing concomitant medications included duloxetine taken for depression, pain from an unspecified start date and ongoing; atenolol taken for hypertension from an unspecified start date and ongoing; amlodipine taken for hypertension from an unspecified start date and ongoing; quetiapine taken for pain, insomnia, depression, start and stop date were not reported. On 28Feb2021, the patient states that she did have a Little pain - clarified later as just to injection site and a little headache. On 01Mar2021, her dominant arm became weak, no pain. On 15Mar2021, she was carrying a bag of recycled papers when someone locked their car; she became startled by the horn and fell.  States she was hurt, her knee is swollen and she hit her head. On 16Mar2021, she was tartled by cell phone and fell.  Also startled when husband yelled at dogs and fell into the counter she was standing by. States she has noticed her asthma has worsened.  States the weather has been windy and dusty. The patient stated she does not know if these symptoms are random or if they are a result of the shot.  Wants to know if these types of side effects have been reported in others. She is scheduled for her second shot tomorrow.  Was excited about getting the vaccine since she has not been to a store since January of last year.  States she has only taken her dog to the vet and had a visit with the doctor who manages her pacemaker once this year.  Wants to get out and do something other than walking the dogs while wearing masks.  Was thrilled about shot and had no problem in the first couple of days.  The falling thing is terrifying.  The loss of use of her dominant arm (right arm); with the left sided weakness from Cerebral Palsy, is more terrifying. The patient stated her arms has been really weak an uncertain if related to vaccines.  States it happened before the falls, arm isn't weak because of the falls because it was weak before she fell. First time hit the ground was terrifying. States she really wants to go get her second vaccine tomorrow.  The outcome of the event Little pain - clarified later as just to injection site and headache was recovered; the event Dominant Arm became weak, no pain  was not recovered; while the other events was unknown.
Patient was given the wrong formulation of Hep A vaccine instead of the Adult formulation of Hep A.  Patient is 31 years old. No adverse reactions noted.
48 hours after vaccines given, pt developed fevers of 101-102; 72 hours after vaccines, pt developed generalized hives and warmth and redness over her knees although no pain or limited range of motion; she otherwise acted OK; no shortness of breath or coughing; she was seen twice on day 3 and 4 following vaccination and did well on frequent Benadryl dosing
SEIZURES; POTASSIUM LEVEL DROPPED; SUGAR LEVELS DROPPED; WHITE BLOOD CELL COUNT DECREASED; NUMBNESS; SWOLLEN LYMPH NODES IN NECK; FELT LIKE DYEING; TEMPERATURE WENT UP; UNABLE TO GET UP; This spontaneous report received from a patient via a company representative concerned a female of unspecified age received via social media. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, Expiry Date: UNKNOWN) dose was not reported, 1 total, administered on 16-MAR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On unspecified date of 2021, the patient's temperature went up and White blood cell count decreased to 1800. The patient's sugar level was dropped although the patient was not having any sugar problems. The patient also experienced swollen lymph nodes in neck, seizures, and numbness. The patient's potassium level was dropped to 3.0. The patient was unable to get up off couch. The patient was hospitalized for 1 day. The patient also felt like dying. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the  temperature went up, White blood cell count decreased, sugar levels dropped, swollen lymph nodes in neck, seizures, numbness, potassium level dropped, unable to get up and felt like dying was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210516164-COVID-19 VACCINE AD26.COV2.S-Seizures, Potassium level dropped, Sugar levels dropped, White blood cell count decreased, Numbness, Swollen lymph nodes in neck, Felt like dyeing, Temperature went up, Unable to get up . This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Child had vaccine. sibling was also in the room and getting vaccines. Patient hopped off the exam table to let her sister get on the table for her vaccines, and sat in a chair. Shortly after she looked pale and felt dizzy and fainted. Mom was at her side and no fall occurred. B/P 100/54 HR 82, cool packs, water given, eventually placed onto exam table to lay down. Rested and observed for over 30 min. Eventually was able to stand and walk without dizziness. Recommended to go home and rest, no driving.
Fluid-filled blister (1 mm) noted on lateral aspect of patient's Left thigh.
Briefly after injection given, pt stood up, said she felt dizzy, chest tightness, headache. 04/17/07-records received from facility for DOS 3/8-3/9/17. DC DX: Neck pressure that was noncardiac.
Patient developed bumps/rash around her mouth soon after leaving the provider's office (~30-40 minutes after vaccine administration). No other reported symptoms. She was asked to return for assessment. Given diphenhydramine 25mg IM. Symptoms completely resolved later the same day. Of note, patient receive influenza vaccination in 11/2019 with no complication (FLUZONE QUAD).
One day after injection of DTaP, legal guardian noted red, warm area around site of injection. Redness was gone by the next AM. still warm to touch and itchy.
Had flu shot on Wed - felt fine; Thurs. sick all day - stomach pain, projectile vomiting X 2 and 5 bowel movements (4 solid and 1 liquid) Fri. felt "weak as a kitten"
Initial unsolicited report received from a nurse on 01 November 2017. This case involves a 65-year-old female patient female patient who was vaccinated with an FLUZONE HIGH DOSE (dose volume, dose in series, batch number, expiry date, route of administration was not reported) on an unknown date. The patient's medical history and concomitant medications were not reported. On an unknown date, following the vaccination, the patient developed reaction of redness, swelling, tenderness. The patient's laboratory data and corrective treatment were not reported. At the time of report the patient was recovering from the events (Patient's symptoms improved 3 week after injection). Follow up information received from a nurse on 19-Dec-2017. This case involve 66-year-old female patient who was vaccinated with 0.5 ml FLUZONE HIGH DOSE (batch number: UI835AA, expiry date: 27 Mar 2018) via intramuscular route in left deltoid on 26 Sep 2017. Any other vaccinations within 4 week prior to date was unknown. On 12 Oct 2017, 16 days post vaccination, the patient had events i.e. topical reaction of redness, swelling, tenderness and decreased size of induration. It was reported that, the patient did not report incident until 12 Oct 2017. Also reported that, patient was advised to apply ice to injection site. On 17 Oct 2017, improvement was noted with decreased size of induration (recovering). List of documents held by sender: none.
Recieved flu vaccine 2 1/2 weeks ago and since that time has had progressive parasthesia of the upper extremeties. Admitted to Hospital 11/15/08, discharged 11/19/08. Guillain Barr syndrome versus transverse myelitis.  2/18/09 Received hospital medical records of 11/15-11/19/2008. FINAL DX: no d/c summary dictated.  Neuro consult: favor transverse myelitis. Records reveal patient experienced progressive tingling/numbness of hands & feet, heaviness of extremities x 2 weeks.  Neuro & Neurosurg consults done.  3/16/09 Received additional hospital medical records of 11/15-11/19/2008. FINAL DX: no d/c summary dictated.   Records consisted of ER records & labs.
Patient fainted and had seizure like symptoms with eyes rolling back in head, clamminess, sweating, severe stomach cramps, blurred vision, and temporary loss of hearing
This spontaneous report was received from a physician via an unspecified reported referring to a patient unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 25-NOV-2015, the patient was vaccinated with a dose of improperly stored PNEUMOVAX 23 "10 PK 0.5mL SD-PFS LLokwTip 10PK" and lot number L014876 with expiration date of 13-JAN-2017 (route of administration and anatomical location were not reported), which was stored at a lowest recorded temperature of 27F (-2.7 Celsius) for 552 hours. The vaccine status was reported as excursion and the storage criteria and the vaccine excursion were reported as "Refrigerator(R)". No concomitant therapies nor adverse effect were reported. No product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. The patient's medical history included hypercholesterolemia. On an unknown date, the patient was vaccinated with ZOSTAVAX, 0.65 ml subcutaneous for prevention of shingles. Concomitant medication included pravastatin. On an unknown date, the patient experienced swelling and redness, approximately 6 inches in diameter, around the injection site, after receiving zoster vaccine live. The patient also experienced that her skin at the injection site appeared broken, like it peeled. The zoster vaccine live injection site was uncomfortable and patient took BENADRYL, which helped her comfort level. Action taken with ZOSTAVAX was not applicable. The patient was recovering from the events. The patient sought medical attention reported as saw the pharmacist. Causality was not reported. Additional information has been requested.
This case was reported by a pharmacist via a sales representative and described the occurrence of injection site pain in a subject of unspecified age and gender who was vaccinated with FLUARIX (GlaxoSmithKline). On an unspecified date the subject received a dose of FLUARIX. Less than one day after vaccination with FLUARIX, the subject experienced injection site pain. The next day, the area was hard and a blister formed. It was reported that it took a week for the events to resolve. The reporter indicated that this event occurred with seven patients that received FLUARIX. Linked cases include A0950536A, A0950541A, A0950542A, A0950543A, A0950545A and A0950546A.
9 x 3 red area - warm to touch - tx: ice PRN and OTC allergy med.
History and physical obtained using telehealth technology with the assistance of the bedside nurse.   a 72 y.o. male  who presents to hospital. The patient states that he developed shortness of breath, coughing and fevers. The symptoms started about 10 days ago. It all started with sore throat and then symptoms progressively worsened with nasal discharge and burning feeling in his lungs. + slight fever in the first 4 days which progressively worsened. Highest was 103.7. No vomiting. + nausea but only with severe coughing spells. + diarrhea x 2 days. No black or bloody stools that he knows of recently. However, about 3 weeks ago he had some blood stools but does have hemorrhoids.    He came in today because the triage nurse convinced him to come in when he was scheduling his wife for COVID testing. His SOB was not severe, he was able to walk out to the mailbox.    He was vaccinated back in febrauary/march x 2 vaccinations.
This spontaneous report as received from a 52 year old female registered nurse reporting on herself with hypertension and rheumatoid arthritis and no drug reactions/allergies who some time last week "approximately in July 2012", she possibly got some reconstituted VARIVAX (Merck) (lot# not reported) on her face, inadvertently. Concomitant therapy included PLAQUENIL. A few days later "Approximately in August 2012" a blister appeared on the nurse's right cheek near her lip that was the size of a nickel. The nurse had a treatment given of hydrocortisone cream and neomycin sulfate, NEOSPORIN ointment. The nurse did not have any lab diagnostics performed. She consulted other nurses in the office. At the time of the report, the nurse had not recovered. Additional information has been requested.
This spontaneous report was received from a physician (and also a company employee) who is a female patient of unknown age, reporting on herself. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 06-JUN-2017, the patient was vaccinated with a dose of ZOSTAVAX in triceps instead of deltoid area (dose, lot# and expiration date were not reported). On 07-JUN-2017, reported as yesterday around 3 pm, the patient experienced injection site reaction/ inflammation of about 20 cm by 6 cm, raised, hot at touch and painful. She also experienced headache and general malaise. The outcome was reported as not recovered/not resolved, as the events were continuing at the time of report. The relatedness between the events and ZOSTAVAX was not reported. Additional information has been requested.
severe shooting pain in arm and rib cage. still happening following shot on 9/15. patient says it fills more similar to joint pain